DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Intepirdine - Launch Insight, 2019
US$ 1,500.00
... clients within 48 hours DelveInsight’s, “Intepirdine, Launch Insight, 2019' report provides comprehensive Insight about the Intepirdine's launch. The report covers all the ... market positioning of the upcoming launch of Intepirdine and will also provide the insight about how Intepirdine will evolve in the market ...
January 2019
50 pages
Lampalizumab - Launch Insight, 2019
US$ 1,500.00
... clients within 48 hours DelveInsight’s, “Lampalizumab, Launch Insight, 2019' report provides comprehensive Insight about the Lampalizumab's launch. The report covers all the ... market positioning of the upcoming launch of Lampalizumab and will also provide the insight about how Lampalizumab will evolve in the ...
January 2019
50 pages
MPC-150-IM - Launch Insight, 2019
US$ 1,500.00
... “MPC-150-IM, Launch Insight, 2019' report provides comprehensive Insight about the MPC-150-IM's launch. The report covers all the indications for which the MPC-150-IM is ... market positioning of the upcoming launch of MPC-150-IM and will also provide the insight about how MPC-150-IM will evolve in the market ...
January 2019
50 pages
Elagolix - Launch Insight, 2019
US$ 1,500.00
... clients within 48 hours DelveInsight’s, “Elagolix, Launch Insight, 2019' report provides comprehensive Insight about the Elagolix's launch. The report covers all the indications ... market positioning of the upcoming launch of Elagolix and will also provide the insight about how Elagolix will evolve in the market ...
January 2019
50 pages
Epidiolex - Launch Insight, 2019
US$ 1,500.00
... clients within 48 hours DelveInsight’s, “Epidiolex, Launch Insight, 2019' report provides comprehensive Insight about the Epidiolex's launch. The report covers all the ... market positioning of the upcoming launch of Epidiolex and will also provide the insight about how Epidiolex will evolve in the market ...
January 2019
50 pages
Emicizumab - Launch Insight, 2019
US$ 1,500.00
... clients within 48 hours DelveInsight’s, “Emicizumab, Launch Insight, 2019' report provides comprehensive Insight about the Emicizumab's launch. The report covers all the ... market positioning of the upcoming launch of Emicizumab and will also provide the insight about how Emicizumab will evolve in the market ...
January 2019
50 pages
Tezacaftor (VX-661) + Ivacaftor - Launch Insight, 2019
US$ 1,500.00
... of market positioning of the upcoming launch of Tezacaftor (VX-661) + Ivacaftor and will also provide the insight about how Tezacaftor (VX-661) + Ivacaftor will evolve in the market as well ...
January 2019
50 pages
Tremelimumab - Launch Insight, 2019
US$ 1,500.00
... the clients within 48 hours DelveInsight’s, “Tremelimumab, Launch Insight, 2019' report provides comprehensive Insight about the Tremelimumab's launch. The report covers all the indications for ... type and mechanism of action Detailed description of non-clinical and clinical studies for all the indications ...
January 2019
50 pages
Lanadelumab - Launch Insight, 2019
US$ 1,500.00
... clients within 48 hours DelveInsight’s, “Lanadelumab, Launch Insight, 2019' report provides comprehensive Insight about the Lanadelumab's launch. The report covers all the ... market positioning of the upcoming launch of Lanadelumab and will also provide the insight about how Lanadelumab will evolve in the market ...
January 2019
50 pages
AR101 - Launch Insight, 2019
US$ 1,500.00
... the clients within 48 hours DelveInsight’s, “AR101, Launch Insight, 2019' report provides comprehensive Insight about the AR101's launch. The report covers all the indications ... of market positioning of the upcoming launch of AR101 and will also provide the insight about how AR101 will evolve in the market as ...
January 2019
50 pages
Brexanolone - Launch Insight, 2019
US$ 1,500.00
... clients within 48 hours DelveInsight’s, “Brexanolone, Launch Insight, 2019' report provides comprehensive Insight about the Brexanolone's launch. The report covers all the ... market positioning of the upcoming launch of Brexanolone and will also provide the insight about how Brexanolone will evolve in the market ...
January 2019
50 pages
Acalabrutinib - Launch Insight, 2019
US$ 1,500.00
... within 48 hours DelveInsight’s, “Acalabrutinib, Launch Insight, 2019' report provides comprehensive Insight about the Acalabrutinib's launch. The report covers all the ... market positioning of the upcoming launch of Acalabrutinib and will also provide the insight about how Acalabrutinib will evolve in the ...
January 2019
50 pages
NuThrax - Launch Insight, 2019
US$ 1,500.00
... clients within 48 hours DelveInsight’s, “NuThrax, Launch Insight, 2019' report provides comprehensive Insight about the NuThrax's launch. The report covers all the indications ... of market positioning of the upcoming launch of NuThrax and will also provide the insight about how NuThrax will evolve in the market ...
January 2019
50 pages
Upadacitinib - Launch Insight, 2019
US$ 1,500.00
... clients within 48 hours DelveInsight’s, “Upadacitinib, Launch Insight, 2019' report provides comprehensive Insight about the Upadacitinib's launch. The report covers all the ... market positioning of the upcoming launch of Upadacitinib and will also provide the insight about how Upadacitinib will evolve in the ...
January 2019
50 pages
Siponimod - Launch Insight, 2019
US$ 1,500.00
... clients within 48 hours DelveInsight’s, “Siponimod, Launch Insight, 2019' report provides comprehensive Insight about the Siponimod's launch. The report covers all the ... market positioning of the upcoming launch of Siponimod and will also provide the insight about how Siponimod will evolve in the market ...
January 2019
50 pages
Allergic Rhinitis - Market Insight, Epidemiology and Market Forecast - 2028
US$ 6,250.00
... Rhinitis Pipeline Analysis Allergic Rhinitis Market Size and Trends Allergic Rhinitis Market Opportunities Impact of upcoming Therapies in Allergic Rhinitis Allergic Rhinitis Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2019
100 pages
Alzheimer’s disease (AD) - Market Insight, Epidemiology and Market Forecast - 2028
US$ 6,250.00
... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Alzheimer’s disease (AD) Report Assessment Current Treatment Practices in Alzheimer’s disease (AD) Unmet Needs in Alzheimer’s disease (AD) Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...
January 2019
100 pages
Anal Cancer - Market Insight, Epidemiology and Market Forecast - 2028
US$ 6,250.00
... in Anal Cancer Anal Cancer Pipeline Analysis Anal Cancer Market Size and Trends Anal Cancer Market Opportunities Impact of upcoming Therapies in Anal Cancer Anal Cancer Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Anal ...
January 2019
100 pages
Asthma - Market Insight, Epidemiology and Market Forecast - 2028
US$ 6,250.00
... Asthma Therapeutic Approaches in Asthma Asthma Pipeline Analysis Asthma Market Size and Trends Asthma Market Opportunities Impact of upcoming Therapies in Asthma Asthma Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Asthma ...
January 2019
100 pages
Asthma -Epidemiology Forecast to 2028
US$ 3,250.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Asthma Key assessments Patient Segmentation in Asthma Asthma Risk & Burden Factors driving growth in a specific Asthma patient population
January 2019
50 pages
Atopic Dermatitis (AD) - Market Insight, Epidemiology and Market Forecast - 2028
US$ 6,250.00
... 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Atopic Dermatitis (AD) Report Assessment Current Treatment Practices in Atopic Dermatitis (AD) Unmet Needs in Atopic Dermatitis (AD) Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...
January 2019
100 pages
Atrial Fibrillation - Market Insight, Epidemiology and Market Forecast - 2028
US$ 6,250.00
... Pipeline Analysis Atrial Fibrillation Market Size and Trends Atrial Fibrillation Market Opportunities Impact of upcoming Therapies in Atrial Fibrillation Atrial Fibrillation Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2019
100 pages
Bile Duct Cancer - Market Insight, Epidemiology and Market Forecast - 2028
US$ 6,250.00
... Duct Cancer Pipeline Analysis Bile Duct Cancer Market Size and Trends Bile Duct Cancer Market Opportunities Impact of upcoming Therapies in Bile Duct Cancer Bile Duct Cancer Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2019
100 pages
Bile Duct Cancer -Epidemiology Forecast to 2028
US$ 3,250.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Bile Duct Cancer Key assessments Patient Segmentation in Bile Duct Cancer Bile Duct Cancer Risk & Burden Factors driving growth in a specific Bile Duct Cancer patient population
January 2019
50 pages
Bladder cancer - Market Insight, Epidemiology and Market Forecast - 2028
US$ 6,250.00
... cancer Bladder cancer Pipeline Analysis Bladder cancer Market Size and Trends Bladder cancer Market Opportunities Impact of upcoming Therapies in Bladder cancer Bladder cancer Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2019
100 pages
Bladder cancer -Epidemiology Forecast to 2028
US$ 3,250.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Bladder cancer Key assessments Patient Segmentation in Bladder cancer Bladder cancer Risk & Burden Factors driving growth in a specific Bladder cancer patient population
January 2019
50 pages
Brain Hemorrhage - Market Insight, Epidemiology and Market Forecast - 2028
US$ 6,250.00
... Hemorrhage Pipeline Analysis Brain Hemorrhage Market Size and Trends Brain Hemorrhage Market Opportunities Impact of upcoming Therapies in Brain Hemorrhage Brain Hemorrhage Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2019
100 pages
Brain Hemorrhage -Epidemiology Forecast to 2028
US$ 3,250.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Brain Hemorrhage Key assessments Patient Segmentation in Brain Hemorrhage Brain Hemorrhage Risk & Burden Factors driving growth in a specific Brain Hemorrhage patient population
January 2019
50 pages
Bronchitis -Epidemiology Forecast to 2028
US$ 3,250.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Bronchitis Key assessments Patient Segmentation in Bronchitis Bronchitis Risk & Burden Factors driving growth in a specific Bronchitis patient population
January 2019
50 pages
Bronchitis - Market Insight, Epidemiology and Market Forecast - 2028
US$ 6,250.00
... in Bronchitis Bronchitis Pipeline Analysis Bronchitis Market Size and Trends Bronchitis Market Opportunities Impact of upcoming Therapies in Bronchitis Bronchitis Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Bronchitis ...
January 2019
100 pages
Chronic Lymphocytic Leukemia (CLL) -Epidemiology Forecast to 2028
US$ 3,250.00
... Key strengths 10 Year Forecast 7MM Coverage Total Cases in Chronic Lymphocytic Leukemia (CLL) Key assessments Patient Segmentation in Chronic Lymphocytic Leukemia (CLL) Chronic Lymphocytic Leukemia (CLL) Risk & Burden Factors driving growth in a specific Chronic Lymphocytic Leukemia (CLL) patient population
January 2019
50 pages
Chronic Myelocytic Leukemia (CML) -Epidemiology Forecast to 2028
US$ 3,250.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Chronic Myelocytic Leukemia (CML) Key assessments Patient Segmentation in Chronic Myelocytic Leukemia (CML) Chronic Myelocytic Leukemia (CML) Risk & Burden Factors driving growth in a specific Chronic Myelocytic Leukemia (CML ...
January 2019
50 pages
Chronic Obstructive Pulmonary Disease (COPD) -Epidemiology Forecast to 2028
US$ 3,250.00
... with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Chronic Obstructive Pulmonary Disease (COPD) Key assessments Patient Segmentation in Chronic Obstructive Pulmonary Disease (COPD) Chronic Obstructive Pulmonary Disease (COPD) Risk & Burden Factors driving growth ...
January 2019
50 pages
Chronic Urticaria Therapeutics -Epidemiology Forecast to 2028
US$ 3,250.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Chronic Urticaria Therapeutics Key assessments Patient Segmentation in Chronic Urticaria Therapeutics Chronic Urticaria Therapeutics Risk & Burden Factors driving growth in a specific Chronic Urticaria Therapeutics patient ...
January 2019
50 pages
Colorectal Cancer (CRC) - Market Insight, Epidemiology and Market Forecast - 2028
US$ 6,250.00
... Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Colorectal Cancer (CRC) Report Assessment Current Treatment Practices in Colorectal Cancer (CRC) Unmet Needs in Colorectal Cancer (CRC) Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...
January 2019
100 pages
Colorectal Cancer (CRC) -Epidemiology Forecast to 2028
US$ 3,250.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Colorectal Cancer (CRC) Key assessments Patient Segmentation in Colorectal Cancer (CRC) Colorectal Cancer (CRC) Risk & Burden Factors driving growth in a specific Colorectal Cancer (CRC) patient population
January 2019
50 pages
Critical Limb Ischemia - Market Insight, Epidemiology and Market Forecast - 2028
US$ 6,250.00
... 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Critical Limb Ischemia Report Assessment Current Treatment Practices in Critical Limb Ischemia Unmet Needs in Critical Limb Ischemia Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...
January 2019
100 pages
Critical Limb Ischemia -Epidemiology Forecast to 2028
US$ 3,250.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Critical Limb Ischemia Key assessments Patient Segmentation in Critical Limb Ischemia Critical Limb Ischemia Risk & Burden Factors driving growth in a specific Critical Limb Ischemia patient population
January 2019
50 pages
Crohn’s Disease (CD) - Market Insight, Epidemiology and Market Forecast - 2028
US$ 6,250.00
... Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Crohn’s Disease (CD) Report Assessment Current Treatment Practices in Crohn’s Disease (CD) Unmet Needs in Crohn’s Disease (CD) Market Attractiveness Market Drivers and Barriers KEY ...
January 2019
100 pages
Cystic fibrosis - Market Insight, Epidemiology and Market Forecast - 2028
US$ 6,250.00
... Cystic fibrosis Pipeline Analysis Cystic fibrosis Market Size and Trends Cystic fibrosis Market Opportunities Impact of upcoming Therapies in Cystic fibrosis Cystic fibrosis Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2019
100 pages
Dermatophytic Onychomycosis - Market Insight, Epidemiology and Market Forecast - 2028
US$ 6,250.00
... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Dermatophytic Onychomycosis Report Assessment Current Treatment Practices in Dermatophytic Onychomycosis Unmet Needs in Dermatophytic Onychomycosis Market Attractiveness Market Drivers and Barriers KEY ...
January 2019
100 pages
Diabetic foot ulcers (DFUs) - Market Insight, Epidemiology and Market Forecast - 2028
US$ 6,250.00
... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Diabetic foot ulcers (DFUs) Report Assessment Current Treatment Practices in Diabetic foot ulcers (DFUs) Unmet Needs in Diabetic foot ulcers (DFUs) Market Attractiveness Market Drivers and Barriers KEY ...
January 2019
100 pages
Diabetic Gastroparesis - Market Insight, Epidemiology and Market Forecast - 2028
US$ 6,250.00
... 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Diabetic Gastroparesis Report Assessment Current Treatment Practices in Diabetic Gastroparesis Unmet Needs in Diabetic Gastroparesis Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...
January 2019
100 pages
Diabetic Macular Edema (DME) - Market Insight, Epidemiology and Market Forecast - 2028
US$ 6,250.00
... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Diabetic Macular Edema (DME) Report Assessment Current Treatment Practices in Diabetic Macular Edema (DME) Unmet Needs in Diabetic Macular Edema (DME) Market Attractiveness Market Drivers and Barriers KEY ...
January 2019
100 pages
Diabetic Nephropathy - Market Insight, Epidemiology and Market Forecast - 2028
US$ 6,250.00
... Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Diabetic Nephropathy Report Assessment Current Treatment Practices in Diabetic Nephropathy Unmet Needs in Diabetic Nephropathy Market Attractiveness Market Drivers and Barriers KEY ...
January 2019
100 pages
Dry eye disease - Market Insight, Epidemiology and Market Forecast - 2028
US$ 6,250.00
... Dry eye disease Pipeline Analysis Dry eye disease Market Size and Trends Dry eye disease Market Opportunities Impact of upcoming Therapies in Dry eye disease Dry eye disease Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition ...
January 2019
100 pages
